DK366589A - Humant protein c-mutant, dens fremstilling og dna, som koder derfor - Google Patents

Humant protein c-mutant, dens fremstilling og dna, som koder derfor Download PDF

Info

Publication number
DK366589A
DK366589A DK366589A DK366589A DK366589A DK 366589 A DK366589 A DK 366589A DK 366589 A DK366589 A DK 366589A DK 366589 A DK366589 A DK 366589A DK 366589 A DK366589 A DK 366589A
Authority
DK
Denmark
Prior art keywords
humant
mutant
protein
manufacturing
dna coding
Prior art date
Application number
DK366589A
Other languages
Danish (da)
English (en)
Other versions
DK366589D0 (da
Inventor
Tamotsu Hashimoto
Masahiro Sato
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of DK366589D0 publication Critical patent/DK366589D0/da
Publication of DK366589A publication Critical patent/DK366589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK366589A 1988-07-26 1989-07-25 Humant protein c-mutant, dens fremstilling og dna, som koder derfor DK366589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18453888 1988-07-26

Publications (2)

Publication Number Publication Date
DK366589D0 DK366589D0 (da) 1989-07-25
DK366589A true DK366589A (da) 1990-01-27

Family

ID=16154955

Family Applications (1)

Application Number Title Priority Date Filing Date
DK366589A DK366589A (da) 1988-07-26 1989-07-25 Humant protein c-mutant, dens fremstilling og dna, som koder derfor

Country Status (8)

Country Link
EP (1) EP0352651A1 (fr)
JP (1) JP2728240B2 (fr)
KR (1) KR910003095A (fr)
AU (1) AU3890689A (fr)
DK (1) DK366589A (fr)
FI (1) FI893545A (fr)
IE (1) IE892412L (fr)
PT (1) PT91268A (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
WO1991009960A1 (fr) * 1989-12-29 1991-07-11 Zymogenetics, Inc. Proteine c hybride
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
US20010006967A1 (en) * 1992-09-21 2001-07-05 Stanley M. Crain Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists
SV1999000067A (es) * 1998-06-01 2000-07-06 Lilly Co Eli Proteina humana c polipeptida ref. x-12279
WO2001036462A2 (fr) * 1999-11-19 2001-05-25 Eli Lilly And Company Derives de proteine c
KR100576180B1 (ko) * 2002-07-27 2006-05-03 주식회사 한화 비폭발성 에멀젼 조성물
WO2004044190A2 (fr) * 2002-11-11 2004-05-27 Maxygen Aps Polypeptides de proteine c de type zymogene
WO2023119230A1 (fr) 2021-12-22 2023-06-29 L'oreal Compositions de modulation de la voie de coagulation et de la voie de nicotinamide-adénine dinucléotide et leurs procédés d'utilisation
KR20230101310A (ko) * 2021-12-29 2023-07-06 주식회사 한화 저비중 에멀젼 폭약 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE93272T1 (de) * 1985-06-27 1993-09-15 Zymogenetics Inc Expression von protein c.
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
JP2799316B2 (ja) * 1987-06-12 1998-09-17 ヘキスト・マリオン・ルセル株式会社 雑種ヒトプロテインｃおよびその遺伝子工学的製法

Also Published As

Publication number Publication date
EP0352651A1 (fr) 1990-01-31
IE892412L (en) 1990-01-26
JPH02167096A (ja) 1990-06-27
DK366589D0 (da) 1989-07-25
FI893545A0 (fi) 1989-07-24
AU3890689A (en) 1990-02-01
KR910003095A (ko) 1991-02-26
PT91268A (pt) 1990-02-08
JP2728240B2 (ja) 1998-03-18
FI893545A (fi) 1990-01-27

Similar Documents

Publication Publication Date Title
NO892834L (no) Imidoperoksikarboksylsyrer, dens fremstilling og anvendelse.
NO891061L (no) Podet a-mono-olefin-kopolymer, dens fremstilling og anvendelse.
DK656189D0 (da) Stabiliseret sucralosekompleks, dets fremstilling og anvendelse
NO905334D0 (no) Selektive katalysatorer og fremstilling derav.
NL192656B (nl) Variabele matrix-decoder.
DE3888418D1 (de) PRML-Kodierung.
DE3688321D1 (de) Entspannungsventil.
DK317288A (da) Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det
DK122687A (da) Polypeptid, dna og anvendelse deraf
NO882858D0 (no) Silikapartikler, fremstilling og anvendelse derav.
DK366589D0 (da) Humant protein c-mutant, dens fremstilling og dna, som koder derfor
DE3774145D1 (de) 3-wegeventil.
DK212789A (da) Utvaerbundet hydrogel, dens fremstilling og anvendelse
FI893450A (fi) Modifierade proteiner.
DK151788A (da) Hybridserpiner og dna, som koder derfor
NO885687D0 (no) Opploeselig rekombinant fcepsilon - reseptor, fremstilling og anvendelse derav.
DE3888715D1 (de) Reg-Gen und dadurch kodiertes Protein.
DK125087D0 (da) Efomycin g., dets fremstilling og anvendelse
FI892254A (fi) Anvaendning av a-aminoboronsyraderivat foer stabilisering av peptid- och proteinlaekemedel.
DK475987A (da) Organisk-kemisk forbindelse, dens fremstilling og anvendelse samt mikroorganismer, som producerer forbindelsen
FI891977A (fi) Redoxaktiva centra.
DK661389D0 (da) Dna-sekvens, som koder for placentaspecifikt protein pp11, dens isolering og anvendelse
DK72091A (da) Superledende sammensaetning, dens fremstilling og anvendelse
DK445887D0 (da) Dna og dets anvendelse samt et produceret, humant alfa2-plas-mininhibitoragtigt protein
NO862769D0 (no) Neodymforbindelse og fremgangsmaate for dens fremstilling.

Legal Events

Date Code Title Description
ATS Application withdrawn